Daniel Andrew Aiello

Discovery and Characterization of Inhibitors of <i>Pseudomonas aeruginosa</i> Type III Secretion

Daniel Andrew Aiello, John D. Williams, Helena Majgier-Báranowska et al. · Antimicrobial Agents and Chemotherapy · 2010 · 128 citations · Full text

Life Sciences, Microbiology, Medical Microbiology +16

Cutting Edge: A Natural Antisense Transcript, AS-IL1α, Controls Inducible Transcription of the Proinflammatory Cytokine IL-1α

Jennie Chan, Maninjay Atianand, Zhaozhao Jiang et al. · The Journal of Immunology · 2015 · 109 citations · Full text

Life Sciences, Immunology, Host-pathogen Interactions +16

AMG 193, a Clinical Stage MTA-Cooperative PRMT5 Inhibitor, Drives Antitumor Activity Preclinically and in Patients with MTAP-Deleted Cancers

Brian Belmontes, Katherine K. Slemmons, Chun Su et al. · Cancer Discovery · 2024 · 70 citations · Full text

Medicine, Oncology, Pharmacology +17

Coumarin-Based Inhibitors of Bacillus anthracis and Staphylococcus aureus Replicative DNA Helicase: Chemical Optimization, Biological Evaluation, and Antibacterial Activities

Bing Li, Ramdas Pai, Di Ming et al. · Journal of Medicinal Chemistry · 2012 · 67 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Mutations in the Pseudomonas aeruginosa Needle Protein Gene <i>pscF</i> Confer Resistance to Phenoxyacetamide Inhibitors of the Type III Secretion System

Nicholas O. Bowlin, John D. Williams, Claire A. Knoten et al. · Antimicrobial Agents and Chemotherapy · 2014 · 65 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +13